I think their biggest problem is the small margins they get due to the amount of competition in their industry.Right now all bets are on idaptive.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025